Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jenneke C. Kasius is active.

Publication


Featured researches published by Jenneke C. Kasius.


Human Reproduction | 2010

Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization

H.M. Fatemi; Jenneke C. Kasius; A. Timmermans; J. van Disseldorp; B.C.J.M. Fauser; P. Devroey; Frank J. Broekmans

BACKGROUND Whether implantation occurs after in vitro fertilization (IVF) depends on the embryo, uterine receptivity or a combination of both. The prevalence of minor intrauterine abnormalities identified at hysteroscopy in cases with a normal transvaginal sonography (TVS) has been recorded to be as high as 20-40%. Diagnosing and treating such pathology prior to initiating IVF/intra-cytoplasmic sperm injection (ICSI), has been widely advocated without high-quality evidence of a beneficial effect. The objective of the current study was to assess, by screening office hysteroscopy, the prevalence of unsuspected intrauterine abnormalities in an asymptomatic population of IVF patients, in whom TVS had not revealed any pathology. METHODS The prevalence of unsuspected intrauterine abnormalities in patients allocated for a randomized controlled trial was prospectively assessed at two tertiary infertility care units: Academic Hospital at the Dutch-speaking Brussels Free University and University Medical Center Utrecht. A total of 678 unselected, asymptomatic, infertile women with a regular indication for a first IVF/ICSI treatment underwent office hysteroscopy. Only asymptomatic patients, aged < or = 42 years, with a normal TVS and no previous hysteroscopy were included. The presence of predefined intrauterine abnormalities was recorded and described in a standardized manner. RESULTS Endometrial polyps were identified in 41 (6%) women and submucous myomas in 6 women (1%). Some women were also diagnosed with intrauterine adhesions (2%) or septa (2%). The overall prevalence of any predefined intrauterine abnormality in this IVF/ICSI population was 11%. CONCLUSIONS The observed prevalence of unsuspected intrauterine abnormalities in asymptomatic patients indicated for their first IVF/ICSI treatment appeared to be clearly lower than previously reported (11 versus 20-45%). This may have implications for the significance of these abnormalities regarding prospects in IVF/ICSI treatment cycles.


Fertility and Sterility | 2011

Antibiotic prophylaxis for hysteroscopy evaluation of the uterine cavity

Jenneke C. Kasius; Frank J. Broekmans; Bart C.J.M. Fauser; Paul Devroey; Human M. Fatemi

OBJECTIVE To assess the prevalence of infectious complications and the protective effect of prophylactic antibiotic treatment after diagnostic office hysteroscopy in asymptomatic, infertile patients with normal results from transvaginal sonography. DESIGN Recording of infectious complications after routine hysteroscopy in the context of a randomized controlled trial; pseudorandomized, center-specific application of antibiotic prophylaxis. SETTING Two tertiary infertility care units. PATIENT(S) Six hundred thirty-one unselected, asymptomatic, infertile women who underwent routine, diagnostic hysteroscopy prior to a first in vitro fertilization (IVF) or intracytoplasmic sperm injection treatment. INTERVENTION(S) Depending on the hospital and according to local protocols, hysteroscopy was performed with or without antibiotic prophylaxis. MAIN OUTCOME MEASURE(S) The prevalence of infectious complications after routine hysteroscopy. RESULT(S) Of the 631 women who underwent routine, diagnostic hysteroscopy, antibiotic prophylaxis was prescribed to 266 women, whereas 365 women underwent the procedure without prophylaxis. Only one infectious complication occurred (0.4%) in a patient who had not undergone therapeutic interventions and had taken antibiotic prophylaxis. This complication was successfully treated with antibiotics on an outpatient basis. CONCLUSION(S) Considering the extremely low risk of infectious complications and the lack of evidence, suggesting a beneficial effect of antibiotic prophylaxis, its use for routine, diagnostic office hysteroscopy should not be recommended.


Fertility and Sterility | 2013

The international agreement study on the diagnosis of the septate uterus at office hysteroscopy in infertile patients

Janine G. Smit; Jenneke C. Kasius; Marinus J.C. Eijkemans; Sebastiaan Veersema; Human M. Fatemi; Evert J.P. Santbrink van; Rudi Campo; Frank J. Broekmans

OBJECTIVE To assess the international agreement on the hysteroscopic diagnosis of septate uterus. DESIGN Interobserver study. SETTING Eight hysteroscopy recordings were put online on the website of the European Society of Gynaecological Endoscopy. PATIENT(S) Asymptomatic, infertile women indicated for a first in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycle. INTERVENTION(S) Office hysteroscopy. MAIN OUTCOME MEASURE(S) The interobserver agreement on the uterine shape and necessity to correct the abnormality found. RESULT(S) Seventy-eight observers from 24 different countries assessed 8 hysteroscopy recordings. The interobserver agreement on uterine shape variations septate and arcuate was fair (intraclass correlation coefficient = 0.27). Observers from the same country reached a significantly higher level of agreement. The agreement on the necessity of correction was poor (intraclass correlation coefficient = 0.17). The most distinct features for diagnosing a septate uterus judged to be the extent of endocavitary bulging and the angle of the bulging structure from the fundal area. CONCLUSION(S) The agreement among international experts on the hysteroscopic diagnosis of the septate uterus was found to be poor. This may have implications for the accuracy of screening hysteroscopy for diagnosing uterine cavity abnormalities in infertile patients. Development of consented definitions for the hysteroscopic diagnosis of septate and arcuate uterus is recommended.


Human Reproduction | 2011

Observer agreement in the evaluation of the uterine cavity by hysteroscopy prior to in vitro fertilization

Jenneke C. Kasius; Frank J. Broekmans; Sebastiaan Veersema; Marinus J.C. Eijkemans; E.J.P. van Santbrink; P. Devroey; B.C.J.M. Fauser; H.M. Fatemi

BACKGROUND Hysteroscopy is known as the most accurate test for diagnosing intrauterine pathology. To optimize fertility treatment, it is increasingly common to perform hysteroscopy as a routine procedure prior to IVF. However, literature on the reproducibility of screening hysteroscopy is lacking. Therefore, the aim of the study was to assess the intra- and inter-observer agreement in the individual evaluation of the uterine cavity using video recordings of hysteroscopy procedures in asymptomatic patients prior to IVF. METHODS Screening hysteroscopies of 123 unselected, asymptomatic, infertile women with an indication for IVF/ICSI treatment were recorded on DVD. After editing, the hysteroscopy performer and three other experienced gynecologists independently assessed all recordings, focusing on the appearance of predefined intrauterine abnormalities (i.e. endometrial polyps, myomas, adhesions or septa). The intra- and inter-observer agreement was calculated and expressed as perfect agreement and κ coefficient or intraclass correlation coefficient. RESULTS In total, 123 hysteroscopy procedures were recorded. After editing and selection, based on the record quality, 107 remained for assessment and analysis. The intraobserver agreement on the appearance of any of the predefined intrauterine abnormalities was substantial (κ = 0.707), whereas the interobserver agreement was moderate (κ = 0.491). Perfect agreement occurred only in 77.6% of the cases. CONCLUSIONS Interobserver agreement among experienced gynecologists appeared to be rather disappointing. The latter may have implications for the diagnostic accuracy of screening hysteroscopy prior to IVF, as well as for its clinical significance in IVF programs.


The Lancet | 2016

Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial

Janine G. Smit; Jenneke C. Kasius; Marinus J.C. Eijkemans; Carolien A. M. Koks; Ronald van Golde; Annemiek W. Nap; G.J. Scheffer; Petra A. P. Manger; Annemieke Hoek; Benedictus C. Schoot; Arne M. van Heusden; Walter K. H. Kuchenbecker; Denise A. M. Perquin; Kathrin Fleischer; Eugenie M. Kaaijk; Alexander Sluijmer; Jaap Friederich; Ramon H. M. Dykgraaf; Marcel van Hooff; Leonie A. Louwe; Janet Kwee; Corry H. de Koning; Ineke C. A. H. Janssen; Femke Mol; Ben Willem J. Mol; Frank J. Broekmans; Helen L. Torrance

BACKGROUND Hysteroscopy is often done in infertile women starting in-vitro fertilisation (IVF) to improve their chance of having a baby. However, no data are available from randomised controlled trials to support this practice. We aimed to assess whether routine hysteroscopy before the first IVF treatment cycle increases the rate of livebirths. METHODS We did a pragmatic, multicentre, randomised controlled trial in seven university hospitals and 15 large general hospitals in the Netherlands. Women with a normal transvaginal ultrasound of the uterine cavity and no previous hysteroscopy who were scheduled for their first IVF treatment were randomly assigned (1:1) to either hysteroscopy with treatment of detected intracavitary abnormalities before starting IVF (hysteroscopy group) or immediate start of the IVF treatment (immediate IVF group). Randomisation was done with web-based concealed allocation and was stratified by centre with variable block sizes. Participants, doctors, and outcome assessors were not masked to the assigned group. The primary outcome was ongoing pregnancy (detection of a fetal heartbeat at >12 weeks of gestation) within 18 months of randomisation and resulting in livebirth. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01242852. FINDINGS Between May 25, 2011, and Aug 27, 2013, we randomly assigned 750 women to receive either hysteroscopy (n=373) or immediate IVF (n=377). 209 (57%) of 369 women eligible for assessment in the hysteroscopy group and 200 (54%) of 373 in the immediate IVF group had a livebirth from a pregnancy during the trial period (relative risk 1·06, 95% CI 0·93-1·20; p=0·41). One (<1%) woman in the hysteroscopy group developed endometritis after hysteroscopy. INTERPRETATION Routine hysteroscopy does not improve livebirth rates in infertile women with a normal transvaginal ultrasound of the uterine cavity scheduled for a first IVF treatment. Women with a normal transvaginal ultrasound should not be offered routine hysteroscopy. FUNDING The Dutch Organisation for Health Research and Development (ZonMW).


Human Reproduction | 2012

The reliability of the histological diagnosis of endometritis in asymptomatic IVF cases: a multicenter observer study

Jenneke C. Kasius; Frank J. Broekmans; Daisy M.D.S. Sie-Go; Claire Bourgain; Marinus J.C. Eijkemans; B.C.J.M. Fauser; Paul Devroey; Human M. Fatemi

BACKGROUND Chronic endometritis is associated with abnormal uterine bleeding, recurrent abortion and infertility. It is a subtle condition, and therefore is difficult to diagnose. The diagnosis is ultimately based on the presence of plasma cells in the endometrial stroma on histopathological examination. Literature on the reproducibility of the diagnosis of chronic endometritis is lacking. Therefore, the aim of the current study was to assess the interobserver agreement of two pathologists in diagnosing chronic endometritis in asymptomatic, infertile patients. METHODS In the context of a randomized controlled trial, an endometrial biopsy was taken during a screening hysteroscopy prior to IVF. All endometrial samples were independently examined by two pathologist. The slides diagnosed with chronic endometritis were replenished with a random sample of the remaining slides up to a total of 100, then exchanged between the two pathologists and reassessed. RESULTS Of the 678 patients who underwent hysteroscopy, 19 patients were diagnosed with at least possible chronic endometritis (2.8%). Perfect agreement between the pathologists, before and after inclusion of 13 slides with additional immunohistochemistry staining, was found in 88 and 86% of reviews, respectively. The interobserver agreement was substantial, with kappa-values of 0.55 and 0.66, respectively. CONCLUSIONS The interobserver agreement in diagnosing chronic endometritis in asymptomatic infertile patients was found to be substantial. Although the diagnostic reliability is sufficient with the methods in the present study, the low prevalence and unknown clinical significance of endometritis warrants further study.


BMC Women's Health | 2012

The inSIGHT study : costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial

Janine G. Smit; Jenneke C. Kasius; Marinus J.C. Eijkemans; Carolien A. M. Koks; Ron van Golde; Jurjen E. Oosterhuis; Annemiek W. Nap; G.J. Scheffer; Petra A. P. Manger; Annemieke Hoek; Mesrure Kaplan; Dick B. C. Schoot; Arne M. van Heusden; Walter K. H. Kuchenbecker; Denise A. M. Perquin; Kathrin Fleischer; Eugenie M. Kaaijk; Alexander Sluijmer; Jaap Friederich; Joop S.E. Laven; Marcel van Hooff; Leonie A. Louwe; Janet Kwee; Jantien J. Boomgaard; Corry H. de Koning; Ineke C. A. H. Janssen; Femke Mol; Ben W. J. Mol; Helen L. Torrance; Frank J. Broekmans

BackgroundIn in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) treatment a large drop is present between embryo transfer and occurrence of pregnancy. The implantation rate per embryo transferred is only 30%. Studies have shown that minor intrauterine abnormalities can be found in 11–45% of infertile women with a normal transvaginal sonography or hysterosalpingography. Two randomised controlled trials have indicated that detection and treatment of these abnormalities by office hysteroscopy after two failed IVF cycles leads to a 9–13% increase in pregnancy rate. Therefore, screening of all infertile women for intracavitary pathology prior to the start of IVF/ICSI is increasingly advocated. In absence of a scientific basis for such a policy, this study will assess the effects and costs of screening for and treatment of unsuspected intrauterine abnormalities by routine office hysteroscopy, with or without saline infusion sonography (SIS), prior to a first IVF/ICSI cycle.Methods/designMulticenter randomised controlled trial in asymptomatic subfertile women, indicated for a first IVF/ICSI treatment cycle, with normal findings at transvaginal sonography. Women with recurrent miscarriages, prior hysteroscopy treatment and intermenstrual blood loss will not be included. Participants will be randomised for a routine fertility work-up with additional (SIS and) hysteroscopy with on-the-spot-treatment of predefined intrauterine abnormalities versus the regular fertility work-up without additional diagnostic tests. The primary study outcome is the cumulative ongoing pregnancy rate resulting in live birth achieved within 18 months of IVF/ICSI treatment after randomisation. Secondary study outcome parameters are the cumulative implantation rate; cumulative miscarriage rate; patient preference and patient tolerance of a SIS and hysteroscopy procedure. All data will be analysed according to the intention-to-treat principle, using univariate and multivariate logistic regression and cox regression. Cost-effectiveness analysis will be performed to evaluate the costs of the additional tests as routine procedure. In total 700 patients will be included in this study.DiscussionThe results of this study will help to clarify the significance of hysteroscopy prior to IVF treatment.Trial registrationNCT01242852


Human Reproduction | 2015

The impact of diagnostic criteria on the reproducibility of the hysteroscopic diagnosis of the septate uterus: a randomized controlled trial

Janine G. Smit; Sanne Overdijkink; Ben Willem J. Mol; Jenneke C. Kasius; Helen L. Torrance; Marinus J.C. Eijkemans; Marlies Y. Bongers; Mark Hans Emanuel; Michael Vleugels; Frank J. Broekmans

STUDY QUESTION Does the use of diagnostic criteria in the hysteroscopic diagnosis of a septate uterus improve inter-observer agreement? SUMMARY ANSWER Pre-set diagnostic criteria slightly improve the inter-observer reproducibility of hysteroscopy in diagnosing a uterine septum, although agreement remains moderate. WHAT IS KNOWN ALREADY The inter-observer agreement on the hysteroscopic diagnosis of the septate uterus has been reported to be poor. STUDY DESIGN, SIZE, DURATION From April 2013 until May 2014, a randomized controlled comparative inter-observer study was performed. A total of 191 gynecologists from 43 countries took part. PARTICIPANTS/MATERIALS, SETTINGS, METHODS Each gynecologist was asked to assess 10 video recordings of hysteroscopy procedures with a specific focus on the internal uterine shape. The hysteroscopies had been performed in subfertile women and women with recurrent miscarriage. The recordings contained images of uterine cavities primarily diagnosed as septate, arcuate or normal. Participating gynecologists were randomized into two groups: one group received diagnostic criteria for a septate uterus before assessment of the videos (DC group), whereas the other group assessed the recordings without instruction (no DC group). The inter-observer agreement, expressed as the intra-class correlation coefficient (ICC), was compared between groups. Main outcomes were the inter-observer agreement on the uterine shape and the necessity of surgical correction. MAIN RESULTS AND THE ROLE OF CHANCE Eighty-six observers were randomized to the DC group and 105 to the no DC group. The ICCs in the diagnosis of a septum were 0.59 versus 0.52, in the DC group and the non-DC group, respectively (P-value: 0.002). The overall agreement on the need for surgical correction was found to be moderate (DC ICC 0.43 versus no DC 0.39, P-value: 0.70). Most importantly, once a septate uterus had been diagnosed, the agreement on the need for surgery was poor in both groups (DC ICC 0.05 versus no DC ICC 0.02, P-value: 0.78). LIMITATIONS, REASONS FOR CAUTION We used video recordings rather than studying real-time hysteroscopic procedures, which may have influenced the accuracy of the assessments. WIDER IMPLICATIONS OF THE FINDINGS The reproducibility of hysteroscopy for the diagnosis of a septate uterus is moderate, even with the use of standardized criteria. The fact that the agreement among physicians on both the diagnosis of a uterine septum, as well as the decision to resect such septum after hysteroscopy is moderate, may imply that hysteroscopy is insufficient as single tool to diagnose and decide on treatment of a septate uterus. STUDY FUNDING/COMPETING INTERESTS No study funding was received and no competing interests are present.


Reproductive Biomedicine Online | 2013

Cost-effectiveness of hysteroscopy screening for infertile women

Jenneke C. Kasius; René J.C. Eijkemans; Ben Willem J. Mol; Bart C.J.M. Fauser; Human M. Fatemi; Frank J.M. Broekmans. Jenneke C. Kasius; Ren

This study assessed the cost-effectiveness of office hysteroscopy screening prior to IVF. Therefore, the cost-effectiveness of two distinct strategies - hysteroscopy after two failed IVF cycles (Failedhyst) and routine hysteroscopy prior to IVF (Routinehyst) - was compared with the reference strategy of no hysteroscopy (Nohyst). When present, intrauterine pathology was treated during hysteroscopy. Two models were constructed and evaluated in a decision analysis. In model I, all patients had an increase in pregnancy rate after screening hysteroscopy prior to IVF; in model II, only patients with intrauterine pathology would benefit. For each strategy, the total costs and live birth rates after a total of three IVF cycles were assessed. For model I (all patients benefit from hysteroscopy), Routinehyst was always cost-effective compared with Nohyst or Failedhyst. For the Routinehyst strategy, a monetary profit would be obtained in the case where hysteroscopy would increase the live birth rate after IVF by ≥ 2.8%. In model II (only patients with pathology benefit from hysteroscopy), Routinehyst also dominated Failedhyst. However, hysteroscopy performance resulted in considerable costs. In conclusion, the application of a routine hysteroscopy prior to IVF could be cost-effective. However, randomized trials confirming the effectiveness of hysteroscopy are needed.


Obstetrical & Gynecological Survey | 2016

Hysteroscopy before In-Vitro Fertilisation (inSIGHT): A Multicentre, Randomised Controlled Trial

Janine G. Smit; Jenneke C. Kasius; Marinus J.C. Eijkemans; Carolien A. M. Koks; Ronald van Golde; Annemiek W. Nap; G.J. Scheffer; Petra A. P. Manger; Annemieke Hoek; Benedictus C. Schoot; Arne M. van Heusden; Walter K. H. Kuchenbecker; Denise A. M. Perquin; Kathrin Fleischer; Eugenie M. Kaaijk; Alexander Sluijmer; Jaap Friederich; Ramon H. M. Dykgraaf; Marcel van Hooff; Leonie A. Louwe; Janet Kwee; Corry H. de Koning; Ineke C. A. H. Janssen; Femke Mol; Ben Willem J. Mol; Frank J. Broekmans; Helen L. Torrance

Since the first successful live birth after in vitro fertilization (IVF) was reported in 1978, more than 5 million children have been born with the help of this and intracytoplasmic sperm injection (ICSI) procedures. However, only approximately 25% to 30% of cycles of IVF and ICSI lead to the birth of a child. The reasons for implantation failure are poorly understood. One major cause of implantation failure is abnormalities of the uterine cavity such as polyps, myoma, and adhesions. Hysteroscopy has been generally regarded as the standard procedure to detect these uterine abnormalities. It is thought to improve pregnancy rates in women scheduled for IVF by detection and surgical removal of uterine cavity abnormalities, dilatation of the cervical canal, or induction of inflammatory reactions in the endometriumby the procedure itself. Hysteroscopy is often performed routinely in infertile women scheduled for their first IVF cycle. However, there are no data from well-designed randomized controlled trials to support this practice. The inSIGHT trial is a pragmatic multicenter randomized clinical trial designed to determine whether routine hysteroscopy before the first IVF treatment cycle increases the live birth rate. The trial was conducted in 7 university hospitals and 15 large general hospitals in the Netherlands. Women eligible for the trial were infertile, scheduled to start their first IVF or ICSI treatment, had no previous hysteroscopy, and had a normal transvaginal ultrasound of the uterine cavity. Subjects were randomly assigned in a 1: 1 ratio to hysteroscopy with treatment of detected intracavitary abnormalities before starting IVF followed by IVF (hysteroscopy group) or to immediate start of IVF treatment (immediate IVF group). Web-based randomization was done with a variable block size to allocate patients to groups and was stratified by center. The doctors, outcome assessors, and participants were not masked to the assigned group. The primary study outcome was an ongoing pregnancy (detection of a fetal heartbeat at > 12weeks of gestation) within 18 months of randomization and a live birth. Analysis was done according to intention to treat. Between May 25, 2011, and August 27, 2013, 750 women were randomized: 373 to the hysteroscopy group and 377 to the immediate IVF group. A live birth occurred during the trial period in 209 (57%) of 369 women in the hysteroscopy group and 200 (54%) of 373 in the immediate IVF group; the relative riskwas 1.06, with a 95% confidence interval of 0.93 to 1.20; P = 0.41. These findings demonstrate that hysteroscopy does not improve live birth rates in infertile women scheduled for their first IVF cycle, who have a normal transvaginal ultrasound of the uterine cavity. Therefore, routine hysteroscopy should not be performed in women with a normal transvaginal ultrasound.

Collaboration


Dive into the Jenneke C. Kasius's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Human M. Fatemi

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Steven Weyers

Universitaire Ziekenhuizen Leuven

View shared research outputs
Top Co-Authors

Avatar

Femke Mol

University of Amsterdam

View shared research outputs
Top Co-Authors

Avatar

Kathrin Fleischer

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar

Annemieke Hoek

University Medical Center Groningen

View shared research outputs
Researchain Logo
Decentralizing Knowledge